Clinical Trials Logo

Chordoma of Sacrum clinical trials

View clinical trials related to Chordoma of Sacrum.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03058289 Completed - Breast Cancer Clinical Trials

A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6

IT-01
Start date: February 9, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

This study evaluates the intratumoral administration of escalating doses of a novel, experimental drug, INT230-6. The study is being conducted in patients with several types of refractory cancers including those at the surface of the skin (breast, squamous cell, head and neck) and tumors within the body such (pancreatic, colon, liver, lung, etc.). Sponsor also plans to test INT230-6 in combination with anti-PD-1 and anti-CTLA-4 antibodies.